Abstract The SS-31 (Elamipretide) 25mg peptide pen provides a precision-calibrated solution of the Szeto-Schiller-31 tetrapeptide, specifically optimised for acute-phase bioenergetic research and dose-ranging protocols. As a cell-permeable aromatic-cationic peptide, SS-31 uniquely targets the inner mitochondrial membrane (IMM) independent of membrane potential. Its primary action involves the structural scavenging of ROS at the source and the electrostatic stabilisation of cardiolipin. This 25mg concentration is the preferred reagent for investigations into acute ischaemia-reperfusion injury and for establishing minimum effective dose (MED) thresholds in models of neuroprotection. It allows researchers to deliver a potent, immediate bolus of mitochondrial support to prevent the opening of the mitochondrial permeability transition pore (mPTP) during critical windows of metabolic stress.

Mechanism and Research Interest

Primary Biological Pathway: Cristae Architecture Stabilisation

The 25mg formulation is frequently utilised to study the immediate structural effects of SS-31 on mitochondrial cristae.

Dysfunctional mitochondria often exhibit “cristae remodeling,” where the tight folds of the inner membrane loosen, impairing the efficiency of the Electron Transport Chain (ETC). Research indicates that SS-31 penetrates the outer membrane and binds to cardiolipin, acting as a “molecular buttress.” This interaction physically tightens the cristae curvature, reducing the distance between electron carriers. The 25mg dose is sufficient to saturate accessible cardiolipin sites in acute models, allowing researchers to observe rapid improvements in the Respiratory Control Ratio (RCR) and ATP turnover.

Secondary Research Finding: Acute Ischaemic Protection

A major application of the 25mg concentration is in models of acute infarction (myocardial or cerebral). In the context of Ischaemia-Reperfusion (I/R) injury, the reintroduction of oxygen typically triggers a massive burst of Reactive Oxygen Species (ROS). SS-31 does not merely scavenge these radicals; it prevents their formation by inhibiting cytochrome c peroxidase activity. Studies using the 25mg pen focus on administering the peptide during the ischaemic event to measure the reduction in infarct size and the preservation of tissue viability post-reperfusion.

Tertiary Research Finding: Renal Bioenergetics

The kidney is highly rich in mitochondria and susceptible to bioenergetic failure. SS-31 is extensively researched for its ability to protect podocytes and tubular cells from metabolic exhaustion. The 25mg format is the standard dosage for models of Acute Kidney Injury (AKI) or diabetic nephropathy. Researchers utilise this concentration to monitor the preservation of the glomerular filtration barrier and the reduction of proteinuria, hypothesising that SS-31 maintains the ATP-dependent cytoskeletal integrity of foot processes.

Long-term Genomic and Safety Observations

While the 25mg dose is often used for acute studies, it also serves as the “maintenance arm” in safety pharmacology. Researchers are investigating whether lower-dose, chronic administration can prevent the age-related drift in mitochondrial gene expression without inducing tolerance. Transcriptomic assays are currently evaluating the expression of SIRT3 and other mitochondrial biogenesis regulators to determine if 25mg provides a “hormetic” stimulus that sustains cellular health over the lifespan of the test subject.

Product Specifications

• Purity: Validated at >98+% via High-Performance Liquid Chromatography (HPLC). The peptide is synthesized with D-arginine and 2,6-dimethyltyrosine (Dmt) to confer protease resistance, ensuring distinct peaks in purity analysis.

• Appearance: The 3ml pen contains a clear, colourless, sterile liquid.

• Precision: The pen ratchet mechanism allows for 0.01ml increment dosing, enabling precise titration for small animal models (e.g., murine or lagomorph) where volume overload is a concern.

• Storage: The product must be stored at 2 degree celcius to 8 degree celcius.

Storage and Shipping Guidelines

Refrigeration and Shelf Life

The SS-31 25mg Pen is a temperature-stable peptide relative to proteins, but strictly requires refrigeration ($2^{\circ}C$ to $8^{\circ}C$) to maintain its pharmacological potency. The shelf life is 12 months in the sealed state. Once opened, the bacteriostatic environment ensures stability for 28 days. As with all mitochondrial-targeting peptides, avoiding repeated temperature fluctuations is critical to preventing micro-precipitation.

Shipping Stability

This product is shipped in validated thermal packaging. SS-31 is stable for up to 72 hours at ambient UK temperatures. However, to minimise any risk of hydrolysis or oxidation, we advise selecting the fastest available shipping option.

Freezing Warning

Do not freeze. Although SS-31 is a small peptide, freezing the reconstituted solution can disrupt the homogeneity of the formulation. Ice crystal formation may lead to the aggregation of the peptide, which can reduce its permeability across the mitochondrial outer membrane. A frozen pen should be discarded.

Why Choose the Peptide Pro 3ml Pen Format?

The SS-31 25mg Pen is the versatile choice for Titration and Acute Studies.

In many experimental designs, the 50mg dose represents a “supraphysiological” load intended for deep repair, whereas the 25mg dose represents a targeted therapeutic window for acute protection.

This format allows researchers to conduct precise dose-response studies (e.g., comparing 1mg/kg vs 5mg/kg) without the waste associated with higher-concentration pens. It is the ideal tool for establishing the Minimum Effective Dose (MED) in new experimental models.

For researchers conducting comparative bioenergetic studies, we recommend referencing:

• SS-31 50mg: (For chronic/longitudinal repair protocols).

• MOTS-c 10mg: (For comparison with mitochondrial-encoded peptides).

Disclaimer

This product is strictly for Research Use Only (RUO). It is not intended for human consumption, injection, therapeutic use (e.g., for mitochondrial myopathy or renal stenosis), or diagnostic procedures. The information provided is for educational and scientific reference only. Purchase is restricted to verified research institutions and qualified individuals. Any evidence of intended misuse for human application will result in immediate order cancellation and blacklisting, in compliance with UK research chemical regulations.